skip to main content

MTX Co-trimoxazole Toxicity — RACP Adult Medicine MCQ

Instant feedback + full explanation. One question, done properly.

HardClinical PharmacologyMTX Co-trimoxazole ToxicityRACP Adult Medicine

A patient taking weekly methotrexate develops mucositis and pancytopenia five days after co-trimoxazole is started. What is the immediate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AStop both interacting medicines, assess urgently for sepsis and organ injury, and give folinic-acid rescue when indicated

The best answer is “Stop both interacting medicines, assess urgently for sepsis and organ injury, and give folinic-acid rescue when indicated”. Co-trimoxazole and methotrexate produce additive antifolate toxicity and may impair methotrexate elimination. Mucositis and pancytopenia require immediate cessation, blood counts, renal and liver assessment, infection management and specialist-guided folinic acid; growth factor or transfusion is used according to severity. Routine folic acid alone is not adequate rescue.

Reference: Australian Prescriber: Managing the drug treatment of rheumatoid arthritis: https://australianprescriber.tg.org.au/articles/managing-the-drug-treatment-of-rheumatoid-arthritis.html